Bare Financial Services’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-216
Closed -$3.12K 1832
2026
Q1
$3.12K Hold
216
﹤0.01% 835
2025
Q4
$3.08K Buy
216
+81
+60% +$796 ﹤0.01% 716
2025
Q3
$1.06K Buy
+135
New +$961 ﹤0.01% 1002

Other funds holding FOLD

Bare Financial Services's FOLD Position: Q2 2026 in Review

Bare Financial Services sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 216 shares — an estimated $3.12K sold.

Bare Financial Services first reported a position in FOLD in Q3 2025 and held it in 3 quarters. The position peaked at $3.12K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Bare Financial Services reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Bare Financial Services sold 216 Amicus Therapeutics shares in Q2 2026, an estimated $3.12K.
  • Bare Financial Services first reported a position in Amicus Therapeutics in Q3 2025 and held it in 3 quarters.
  • Bare Financial Services's Amicus Therapeutics position peaked at $3.12K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.